Important article published yesterday in Nature.
"the largest study to date of acute cardiac outcomes after SARS-CoV-2 vaccination or infection, the first to compare the risk of cardiac events between different vaccine products and SARS-CoV2 infection"
nature.com/articles/s4159…
"the largest study to date of acute cardiac outcomes after SARS-CoV-2 vaccination or infection, the first to compare the risk of cardiac events between different vaccine products and SARS-CoV2 infection"
nature.com/articles/s4159…
"First, there was an increase in the risk of myocarditis
within a week of receiving the first dose of both adenovirus and mRNA vaccines, and a higher increased risk after the second dose of both mRNA vaccines."
Increased myocarditis risk range is 1 to 10 per million doses.
within a week of receiving the first dose of both adenovirus and mRNA vaccines, and a higher increased risk after the second dose of both mRNA vaccines."
Increased myocarditis risk range is 1 to 10 per million doses.
"Second, in the same population, there was a greater risk of myocarditis, pericarditis and cardiac arrhythmia following SARS-CoV-2 infection."
Increased myocarditis risk is 40 per million infections.
Increased myocarditis risk is 40 per million infections.
"Third, the increased risk of myocarditis after vaccination was higher in persons aged under 40 years."
Increased myocarditis risk range higher from vaccination (2-15 cases per million) than from infection (10 per million) for under 40 yo subgroup.
Increased myocarditis risk range higher from vaccination (2-15 cases per million) than from infection (10 per million) for under 40 yo subgroup.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
